AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of AMPHORA® Contraceptive Vaginal Gel

Trial Profile

AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of AMPHORA® Contraceptive Vaginal Gel

Recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Aug 2017

At a glance

  • Drugs Citric acid/lactic acid/potassium bitartrate (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Acronyms AMPOWER
  • Sponsors Evofem
  • Most Recent Events

    • 29 Jul 2017 New trial record
    • 27 Jul 2017 According to an Evofem media release, first patient has been enrolled in the study and the company expects to complete the study in the fourth quarter of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top